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Background: Various types of gastro-intestinal complications have already
been reported after atrial fibrillation (AF) radiofrequency ablation. The objec-
tive of this prospective study was to assess the incidence of esogastric injuries
after pulmonary vein isolation (PVI) with the cryoballoon catheter (Arctic
Front, Cryocath, Quebec, Canada).
Methods: Between December 2007 and April 2009, 25 patients (15 males,
mean age 55 years old) with symptomatic, drug refractory, paroxysmal (n= 24)
or persistent (n= 1) AF underwent circumferential antral PVI using a cryobal-
loon catheter. Post-procedural upper gastro-intestinal endoscopy was system-
atically performed on the following day.
Results: All procedures were performed in patients using a double lumen
23 or 28 mm cryoballoon catheter, with a mean maximal temperature of – 45.5
± 19.7°C. Out of the 100 veins treated by the cryoballoon technique, 93 were
completely isolated (93%). The number of balloon applications per vein was
2.2 ± 0.7 and the mean procedure time was 158.5 ± 28.7 minutes. Endoscopy
found gastroparesia in 4 patients (16%, 2 gastric bezoar and 2 severe gastric
stasis) which were considered as likely related to the ablation and due to vagal
injury. All patients were asymptomatic. In 13 cases (52%), endoscopic abnor-
malities were considered as fortuitous (peptic gastritis and esophagitis, n=8;
gastric ulcer, n=1; hiatal hernia, n=5; esophageal lipoma, n=1). In one case,
the endoscopy revealed a Mallory Weiss syndrome, presumably connected to
pre-operative trans-esophageal echocardiography. Esograstric endoscopy was
normal in only 8 cases (32%).
Conclusion: Cryoballoon catheter ablation for AF is associated with an
unusual high incidence of gastroparesia (16%) which could be related to pro-
cedural periesophageal vagal nerve damage.
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Introduction: Although most ventricular tachycardia (VT) originates from
the endocardium, epicardial substrate requiring epicardial mapping/ablation is
increasingly recognized. There is, however, limited information about its
safety and mid-term complications.
Methods: All patients undergoing VT ablation in 3 tertiary care centers
between 2001 and 2007 were included in this study. Of 913 VT ablations, 156
procedures (17%) involved epicardial mapping and/or ablation. These were
performed in 134 patients (109 male, 56 ±15yo), after a previous VT ablation
in 119 (76%). The underlying substrate was ischemic cardiomyopathy (CMP)
in 51, non ischemic CMP in 39, Arrhythmogenic Right Ventricular Cardiomy-
opathy in 13, and others types of CMPs in 31.
Results: Epicardial access was obtained via percutaneous subxyphoid
puncture in 136 procedures, by a surgical subxyphoid approach in 14 and
during open heart surgery in 6. Epicardial ablation (13±12min; median:
10min) was performed in 121/156 procedures (78%). Nineteen patients subse-
quently required repeat procedure(s) and the epicardium could be re-accessed
in all but one patient.
A total of 8/156 (5 %) major complications related to pericardial access
were observed acutely: 7 epicardial bleeding (>100cc) [all bleeding stopped
spontaneously] and 1 coronary stenosis.
After a mean follow-up of 23±21months, 3 delayed complications related
to pericardial access, were noted (1 major pericardial inflammatory reaction, 1
delayed tamponade and 1 coronary occlusion 2 weeks after the procedure).
Conclusion: VT ablation requires epicardial mapping and ablation in 121/
913 (13%) procedures with a risk of 5% and 2% of acute and delayed major
complications related to epicardial access.
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Introduction: Ischemic stroke (IS) is a frequent pathology, burdened by
high rate of recurrence and significant morbidity and mortality. There are
several causes of IS, affecting prognosis, outcomes and management, but in
many cases the etiology remains undetermined despite comprehensive
research. We hypothezised that atrial fibrillation (AF) was largely involved
in this pathology but was underdiagnosed by standard methods. The aim of
this study was to determine the incidence of AF in cryptogenic IS, by using
continuous monitoring of the heart rate over several months. The secondary
objective was to test the predictive value of atrial vulnerability study towards
spontaneous AF.
Methods and results: We prospectively enrolled 24 patients under 75
years: 15 men and 9 women of mean age 48.8± 13.6 years who experi-
enced cryptogenic IS presumed of cardioembolic mechanism within the
last 4 months. Any cause of IS was excluded by normal 12-lead ECG, 24-
hour Holter monitoring, echocardiography, cervical Doppler, haematolog-
ical and inflammatory tests. All patients underwent electrophysiological
study. 7 patients (29.2%) had inducible arrhythmia during programmed
atrial stimulation and 9 (37.5%) had a latent vulnerability index (LVI)
<2.5. Patients were secondarily implanted with an implantable loop
recorder (ILR) (MedtronicTM Reveal Plus 9526) to look for spontaneous
AF over a mean follow-up interval of 14.5 months. No sustained
arrhythmia was found. Only one patient had non significant AF access
(<30 s). In this patient, it was not triggered sustained arrhythmia but the
LVI was low.
Conclusion: This study shows that contrary to what was expected, AF does
not appear to be a common pathology in patients under 75 years with unex-
plained IS. The use of ILR should not be generalized in the systematic assess-
ment of these patients because of its unprofitability. Finally this study attests
the poor value of atrial vulnerability study for predicting spontaneous AF in
such patients.
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Pulmonary vein isolation (PVI) became the usual approach for the treat-
ment of atrial fibrillation (AF) refractory to medical antiarrhythmic treatment.
Pulmonary vein isolation with a cryoballoon is a new technique wich allows a
circumferential PVI.
Aim: to assess the feasibility, efficacy, and safety of using a cryoballoon
catheter to achieve pulmonary vein isolation (PVI).
Methods: 67 patients with symptomatic AF (50 paroxysmal) were
accepted for PVI with a cryoballoon. They were seen on an outpatient basis
every three months or if they complained of AF-related symptoms. A 48-hour
Holter recording was used to document asymptomatic AF at 3 months. We
compiled acute and mid-term results and reviewed complications and safety
issues with regard to the procedure.
Results: 217 (85%) veins were successfully isolated with a single cryobal-
loon application. The success of isolation depends on the extent of venous
occlusion during application. The average procedure time was 178 minutes;
the average fluoroscopy time, 43 minutes. Patients were followed for a median
of 9.7 months. Eighty-five percent were free from recurrent AF or arrhythmia-
related symptoms. Freedom from AF results were more significant among
patients with paroxysmal AF (90% of patients Vs 60% among patients with
persistent AF). The phrenic nerve palsy (PNP) is the most frequent complica-
tion (6 cases), it is always reversible. Four patients have presented a minor
pericardic effusion.
Conclusions: despite the occurrence of minor complications, PVI using a
cryoballoon is feasible with a high rate of acute success and excellent mid-
term results. These results, comparable to those obtained with radiofrequency
(RF) energy, have helped make cryoballoon ablation our first-line therapy for
the treatment of paroxysmal AF.
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Objective: To assess the usefulness of miniature transoesophageal echocar-
diography using AcuNav probe (10F, TEO-AcuNav) for the monitoring of
atrial fibrillation ablation in awake patients.
Methods: TEO-AcuNaV was used in 30 consecutive patients (55±13
years, 67% male) referred for atrial fibrillation ablation (76% paroxysmal,
24% persistent or permanent) to guide trans-septal catheterisation and to iden-
tify the occurrence of thrombosis during the procedure.
Results: Transseptal catheterisation monitored by TEO-AcuNaV was suc-
cessfully performed in all patients but one where standard TEE confirmed the
presence of a left auricular thrombus. Importantly, TEO-AcuNav identified a
right sided catheter related thrombus leading to retrieve the catheter. In addi-
tion, 3 pericardial effusions were documented during the procedure. Finally,
TEO-AcuNAV was perfectly tolerated in all patients even though maintained
awake.
Conclusion: Transoesophageal AcuNav echography is safe and well toler-
ated and allows efficacious monitoring of atrial fibrillation ablation without
general anesthesia.
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Introduction: radio-frequency (RF) ablation of premature ventricular
beats (PVB) has been only reported as isolated cases or in short series.
Methods: 34 successive pts (25 men, 53 ± 18 yo) underwent RF ablation
of frequent or symptomatic isolated PVB at our institution from 2005 to 2009.
Indication, technique and results were reported.
Results: 43 RF ablation of PVB was performed for post-ischemic electrical
storm in 7 pts (6 men), for symptomatic PVB in 7 (3 men) and for suspected
VPB-induced tachycardiomyopathy in 20 (16 men) with 1,2 procedure/pt. RF
was performed in each case using pace mapping and activation mapping with
conventional technique. RF ablation of PVB during intractable post-ischemic
electrical storm was initially successful in each pt but fatal electrical storm
recurred in 4 during the following days. PVB were targeted in the left septal
Purkinje network. 10 procedures were performed in 7 pts for palpitations or syn-
cope, leading to complete or partial clinical success in 6 (PVB reduction 9400 ±
12200 to 420 ± 610 /24h, NS). 25 procedures were performed for suspected
VPB-induced tachycardiomyopathy in 20 pts leading to complete success in 9
pts and to significant decrease in VPB in 5 pts. Mean VPB/24h was 17800 ±
8600 before and 3410 ± 8150 after and 125 ± 230 at 11 ± 6 months follow-up
(p=0,0005). EF increase from 41 ± 8 to 53 ± 7 % (p<0,0001). Main locations of
the PVB were RVOT, right or left aortic cusps, left basal septum, LVOT and
laterobasal LV. Complications were asymptomatic mild pericardial effusion in
one pt, transient AV block in one and transient ischemic stroke in one.
Conclusions: RF ablation of PVB may be indicated if highly symptomatic,
for electrical storm or for suspected tachycardiomyopathy with good although
imperfect success rate
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